Start Submission Become a Reviewer

Reading: Management of dengue infection: improving morbidity


A- A+
Alt. Display

Review Articles

Management of dengue infection: improving morbidity


Vithanage Pujitha Wickramasinghe

University of Colombo, Colombo, LK
About Vithanage Pujitha

Senior Lecturer, Department of Paediatrics, Faculty of Medicine

X close


Dengue is a vector borne disease, prevalent in the tropics in epidemic proportions. In recent years it has become one of the highest mortality causing communicable diseases in the tropics. Its pathophysiology is not completely understood. In the absence of a definitive treatment modality, supportive care is the most important tool.  Having a better understanding of the haematological and biochemical changes is of paramount importance in order to provide effective supportive care to achieve speedy recovery with minimum morbidity and mortality. Although several candidate vaccines have been produced most are still undergoing phase III clinical trials.


This article intends to discuss identified and postulated pathophysiological modalities in dengue infection and possible therapeutic/management options that could be adopted to reduce dengue morbidity and mortality.
How to Cite: Wickramasinghe, V.P., 2019. Management of dengue infection: improving morbidity. Ceylon Journal of Medical Science, 56(1), pp.3–11. DOI:
Published on 30 Dec 2019.
Peer Reviewed


  • PDF (EN)

    comments powered by Disqus